LaunchPad Café, LTD, a subsidiary of Ventana Biotech, Inc. (VNTA), Announces its First financing client
LaunchPad Café, LTD, a subsidiary of Ventana Biotech, Inc. (VNTA) Announces its First financing client LaunchPad Café, Ltd, the finance…
Pharmaceuticals, Biotechnology and Life Sciences
LaunchPad Café, LTD, a subsidiary of Ventana Biotech, Inc. (VNTA) Announces its First financing client LaunchPad Café, Ltd, the finance…
SHANGHAI, China, June 20, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing…
BASEL, Switzerland, June 16, 2022 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine care for women…
NEW YORK, June 16, 2022 (GLOBE NEWSWIRE) — GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic…
Call to be held on Tuesday, June 21st at 1:00 PM Eastern TimeLAVAL, Quebec, June 16, 2022 (GLOBE NEWSWIRE) —…
SAN CARLOS, Calif., June 16, 2022 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on…
Clinical update call featuring LAVA-051 investigator Dr. Arnon Kater and Company management summarized initial Phase 1/2a clinical trial data presented…
BRIDGEWATER, N.J., June 16, 2022 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical…
Management to discuss progress on its programs, annual stockholders’ meeting proposals Webcast to be held on June 22 at 1:00…
Extends Cash Runway into 2H 2024BOSTON, June 16, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a commercial-stage…